Clinical significance and biological roles of TRIM24 in human bladder carcinoma

Tumor Biology

Volumn 36, Issue 9, 2015, Pages 6849-6855

  Xue, Dongwei ^a   Zhang, Xiuwei ^a   Zhang, Xilin ^a   Liu, Jia ^a   Li, Ning ^a   Liu, Chunlai ^a   Liu, Yili ^a   Wang, Ping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Bladder cancer; NF B; Proliferation; TRIM24

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN D1; CYCLIN E; I KAPPA B KINASE ALPHA; PROTEIN; SMALL INTERFERING RNA; TRIM24 PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRIM24 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER CELL; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FILTERS AND MEMBRANES; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; AGED; APOPTOSIS; BIOSYNTHESIS; BLADDER TUMOR; CANCER STAGING; CARCINOMA; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION;

AGED; APOPTOSIS; CARCINOMA; CARRIER PROTEINS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84947128781     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3393-3     Document Type: Article

References (22)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
2. Meng XD et al. Increased SPHK1 expression is associated with poor prognosis in bladder cancer. Tumour Biol. 2014;35(3):2075–80.
3. Liu J et al. Clinical significance of UNC5B expression in bladder cancer. Tumour Biol. 2013;34(4):2099–108.
4. Le Douarin B et al. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 1995;14(9):2020–33.
5. Le Douarin B et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 1996;15(23):6701–15.
6. Le Douarin B et al. TIF1 alpha: a chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors? Biochem Soc Trans. 1997;25(2):605–12.
7. Tsai WW et al. TRIM24 links a non-canonical histone signature to breast cancer. Nature. 2010;468(7326):927–32.
8. Khetchoumian K et al. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat Genet. 2007;39(12):1500–6.
9. Chambon M et al. Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. Am J Pathol. 2011;178(4):1461–9.
10. Li H et al. Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer. PLoS One. 2012;7(5):e37657.
11. Cui Z et al. TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes. PLoS One. 2013;8(5):e63887.
12. Liu X et al. Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma. PLoS One. 2014;9(1):e85462.
13. Chambon M et al. Prognostic significance of TRIM24/TIF-1alpha gene expression in breast cancer. Am J Pathol. 2011;178(4):1461–9.
14. Zhang LH, et al. TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene. 2014.
15. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007;98(5):629–35.
16. Witzel II, Koh LF, Perkins ND. Regulation of cyclin D1 gene expression. Biochem Soc Trans. 2010;38(Pt 1):217–22.
17. Fristrup N et al. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. Am J Pathol. 2013;182(2):339–49.
18. Hennessy BT et al. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005;4(12):988–1004.
19. Lu B et al. Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway. Tumour Biol. 2012;33(6):2007–17.
20. Yu Y et al. AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. Tumour Biol. 2012;33(2):307–14.
21. Man X et al. Clinical significance and biological roles of CARMA3 in human bladder carcinoma. Tumour Biol. 2014;35(5):4131–6.
22. Tang ZP et al. Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways. Tumour Biol. 2013;34(5):2835–42.